Stay updated on Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial page.

Latest updates to the Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial page
- Check3 days agoChange Detected- Updated page revision from v3.4.2 to v3.4.3. - No substantive changes to study details or user-facing content.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe Study Record Dates now display 'Results Submitted' instead of 'No Results Posted', indicating that results have been submitted.SummaryDifference0.1%

- Check32 days agoChange DetectedAn update adds a new footer revision tag 'Revision: v3.4.2' and removes an outdated 'Notice' about government funding as well as the prior 'Revision: v3.4.1' tag. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check39 days agoChange DetectedA site-wide notice about government funding and NIH Clinical Center operations was added, and the site revision was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check46 days agoChange DetectedUI updates include showing the glossary toggle and new metadata labels (Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0), while the corresponding older labels (Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check60 days agoChange DetectedRevision: v3.3.4 appears in the page footer replacing the previous v3.3.3. The update does not alter study details or eligibility information.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial page.